Rare variants in the YKT6 gene cause new neurological disorder, study finds

FHS
April 2, 2024
2:45 am

A recent collaborative study has discovered rare variants in the YKT6 gene as the cause of a new neurological disorder characterized by developmental delays along with severe progressive liver disease and a potential risk for liver cancer.

Philips recalls MRI machines due to risk of explosion

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Philips recalled certain magnetic resonance

December 22, 2023

AI Therapy companion ‘replika’ gains traction among lonely students

The young adult mental health outcomes of using a GPT3-enabled chatbot.

January 24, 2024

SYNLAB AG: Cinven announces public acquisition offer

SYNLAB AG / Key word(s): Agreement/Strategic Company Decision SYNLAB AG: Cinven announces public acquisition offer | Conclusion of Investment Agreement 29-Sep-2023 / 08:17 CET/CEST Disclosure

September 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.